Skip to main content
NCBI home page
Heart logoLink to Heart
. 2000 May;83(5):577–578. doi: 10.1136/heart.83.5.577

Plasma fibrinogen, soluble P-selectin, and von Willebrand factor in aortic valve disease: evidence for abnormal haemorheology, platelet activation, and endothelial dysfunction

I GOLDSMITH, A BLANN, R PATEL, G LIP
PMCID: PMC1760819  PMID: 10768913

Full Text

The Full Text of this article is available as a PDF (101.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bamford J., Sandercock P., Dennis M., Warlow C., Jones L., McPherson K., Vessey M., Fowler G., Molyneux A., Hughes T. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry. 1988 Nov;51(11):1373–1380. doi: 10.1136/jnnp.51.11.1373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Biasucci L. M., Vitelli A., Liuzzo G., Altamura S., Caligiuri G., Monaco C., Rebuzzi A. G., Ciliberto G., Maseri A. Elevated levels of interleukin-6 in unstable angina. Circulation. 1996 Sep 1;94(5):874–877. doi: 10.1161/01.cir.94.5.874. [DOI] [PubMed] [Google Scholar]
  3. Blann A. D., Lip G. Y. Hypothesis: is soluble P-selectin a new marker of platelet activation? Atherosclerosis. 1997 Feb 10;128(2):135–138. doi: 10.1016/s0021-9150(96)05980-1. [DOI] [PubMed] [Google Scholar]
  4. Fuster V., Badimon L., Badimon J. J., Chesebro J. H. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med. 1992 Jan 30;326(5):310–318. doi: 10.1056/NEJM199201303260506. [DOI] [PubMed] [Google Scholar]
  5. Lafont A., Libby P. The smooth muscle cell: sinner or saint in restenosis and the acute coronary syndromes? J Am Coll Cardiol. 1998 Jul;32(1):283–285. doi: 10.1016/s0735-1097(98)00216-2. [DOI] [PubMed] [Google Scholar]
  6. Lip G. Y., Blann A. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res. 1997 May;34(2):255–265. doi: 10.1016/s0008-6363(97)00039-4. [DOI] [PubMed] [Google Scholar]
  7. Lip G. Y., Rumley A., Dunn F. G., Lowe G. D. Thrombogenesis in mitral regurgitation and aortic stenosis. Angiology. 1996 Dec;47(12):1117–1125. doi: 10.1177/000331979604701201. [DOI] [PubMed] [Google Scholar]
  8. Liuzzo G., Buffon A., Biasucci L. M., Gallimore J. R., Caligiuri G., Vitelli A., Altamura S., Ciliberto G., Rebuzzi A. G., Crea F. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation. 1998 Dec 1;98(22):2370–2376. doi: 10.1161/01.cir.98.22.2370. [DOI] [PubMed] [Google Scholar]
  9. Pietersma A., Kofflard M., de Wit L. E., Stijnen T., Koster J. F., Serruys P. W., Sluiter W. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation. 1995 Mar 1;91(5):1320–1325. doi: 10.1161/01.cir.91.5.1320. [DOI] [PubMed] [Google Scholar]
  10. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999 Jan 14;340(2):115–126. doi: 10.1056/NEJM199901143400207. [DOI] [PubMed] [Google Scholar]
  11. Stein P. D., Sabbah H. N. Turbulent blood flow in the ascending aorta of humans with normal and diseased aortic valves. Circ Res. 1976 Jul;39(1):58–65. doi: 10.1161/01.res.39.1.58. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES